CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,000 | -93.5% | 1,267 | -91.7% | 0.00% | -100.0% |
| Q1 2022 | $31,000 | -51.6% | 15,203 | -35.6% | 0.00% | -50.0% |
| Q4 2021 | $64,000 | -26.4% | 23,623 | +58.5% | 0.00% | -77.8% |
| Q3 2020 | $87,000 | +2800.0% | 14,907 | +3812.6% | 0.01% | – |
| Q2 2020 | $3,000 | -62.5% | 381 | -70.2% | 0.00% | -100.0% |
| Q1 2020 | $8,000 | -83.0% | 1,279 | -89.4% | 0.00% | -71.4% |
| Q3 2019 | $47,000 | +30.6% | 12,029 | +725.6% | 0.01% | 0.0% |
| Q1 2019 | $36,000 | +3500.0% | 1,457 | +5103.6% | 0.01% | – |
| Q4 2018 | $1,000 | -98.7% | 28 | -98.9% | 0.00% | -100.0% |
| Q3 2018 | $76,000 | +1166.7% | 2,596 | +2118.8% | 0.03% | +766.7% |
| Q1 2018 | $6,000 | -75.0% | 117 | -67.4% | 0.00% | -83.3% |
| Q4 2017 | $24,000 | +2300.0% | 359 | +5028.6% | 0.02% | +1700.0% |
| Q2 2017 | $1,000 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |